Zhao Wu

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

Jiasheng Wang, Yongxian Hu, Shuye Yang et al. · Biology of Blood and Marrow Transplantation · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +16

Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size

Hong Zhao, Qi Zhu, Chi Zhang et al. · Biomedicine & Pharmacotherapy · 2020 · 107 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia

Yongxian Hu, Jiasheng Wang, Guoqing Wei et al. · Bone Marrow Transplantation · 2018 · 47 citations

Life Sciences, Immunology, Oncology +12

Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients

Xiaoqin Dong, Zhao Wu, Hong Zhao et al. · Journal of Viral Hepatitis · 2018 · 44 citations

Medicine, Clinical Sciences, Pathology +17